Molecular Mechanisms of Viral and Host Cell Substrate Recognition by Hepatitis C Virus NS3/4A Protease

被引:42
|
作者
Romano, Keith P. [1 ]
Laine, Jennifer M. [1 ]
Deveau, Laura M. [1 ]
Cao, Hong [1 ]
Massi, Francesca [1 ]
Schiffer, Celia A. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
CRYSTAL-STRUCTURE; INHIBITOR; REPLICATION; VARIANTS; CLEAVAGE;
D O I
10.1128/JVI.00377-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C NS3/4A protease is a prime therapeutic target that is responsible for cleaving the viral polyprotein at junctions 3-4A, 4A4B, 4B5A, and 5A5B and two host cell adaptor proteins of the innate immune response, TRIF and MAVS. In this study, NS3/4A crystal structures of both host cell cleavage sites were determined and compared to the crystal structures of viral substrates. Two distinct protease conformations were observed and correlated with substrate specificity: (i) 3-4A, 4A4B, 5A5B, and MAVS, which are processed more efficiently by the protease, form extensive electrostatic networks when in complex with the protease, and (ii) TRIF and 4B5A, which contain polyproline motifs in their full-length sequences, do not form electrostatic networks in their crystal complexes. These findings provide mechanistic insights into NS3/4A substrate recognition, which may assist in a more rational approach to inhibitor design in the face of the rapid acquisition of resistance.
引用
收藏
页码:6106 / 6116
页数:11
相关论文
共 50 条
  • [21] Internal cleavages of hepatitis C virus NS3 induced by P1 mutations at the NS3/4A cleavage site
    Hou, Xiaohong
    Yang, Wengang
    Zhao, Yongsen
    Agarwal, Atul
    Huang, Mingjun
    VIROLOGY, 2009, 383 (02) : 271 - 278
  • [22] Development of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus Infection
    Pan, Kao-Lu
    Lee, Jin-Ching
    Sung, Hsing-Wen
    Chang, Teng-Yuang
    Hsu, John T. -A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4825 - 4834
  • [23] Evaluating the inhibitory effect of eight compounds from Daphne papyracea against the NS3/4A protease of hepatitis C virus
    Wei, Ying
    Yang, Jian
    Kishore Sakharkar, Meena
    Wang, Xia
    Liu, Qin
    Du, Jiang
    Zhang, Jing-Jie
    NATURAL PRODUCT RESEARCH, 2020, 34 (11) : 1607 - 1610
  • [24] Hepatitis C Virus NS3 Protease Is Activated by Low Concentrations of Protease Inhibitors
    Dahl, Goran
    Arenas, Omar Gutierrez
    Danielson, U. Helena
    BIOCHEMISTRY, 2009, 48 (48) : 11592 - 11602
  • [25] In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
    Ng, Teresa I.
    Tripathi, Rakesh
    Reisch, Thomas
    Lu, Liangjun
    Middleton, Timothy
    Hopkins, Todd A.
    Pithawalla, Ron
    Irvin, Michelle
    Dekhtyar, Tatyana
    Krishnan, Preethi
    Schnell, Gretja
    Beyer, Jill
    McDaniel, Keith F.
    Ma, Jun
    Wang, Guoqiang
    Jiang, Li-Juan
    Or, Yat Sun
    Kempf, Dale
    Pilot-Matias, Tami
    Collins, Christine
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [26] Molecular modeling based approach, synthesis and in vitro assay to new indole inhibitors of hepatitis C NS3/4A serine protease
    Ismail, Nasser S. M.
    Hattori, Masao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (01) : 374 - 383
  • [27] Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure
    Rudd, Michael T.
    McCauley, John A.
    Butcher, John W.
    Romano, Joseph J.
    McIntyre, Charles J.
    Nguyen, Kevin T.
    Gilbert, Kevin F.
    Bush, Kimberly J.
    Holloway, M. Katharine
    Swestock, John
    Wan, Bang-Lin
    Carroll, Steven S.
    DiMuzio, Jillian M.
    Graham, Donald J.
    Ludmerer, Steven W.
    Stahlhut, Mark W.
    Fandozzi, Christine M.
    Trainor, Nicole
    Olsen, David B.
    Vacca, Joseph P.
    Liverton, Nigel J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03): : 207 - 212
  • [28] Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors
    Geitmann, Matthis
    Dahl, Goran
    Danielson, U. Helena
    JOURNAL OF MOLECULAR RECOGNITION, 2011, 24 (01) : 60 - 70
  • [29] Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a
    Guo, Zhuyan
    Black, Stuart
    Hu, Yuan
    McMonagle, Patricia
    Ingravallo, Paul
    Chase, Robert
    Curry, Stephanie
    Asante-Appiah, Ernest
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (15) : 6202 - 6212
  • [30] Prediction of substrate specificity in NS3/4A serine protease by biased sequence search threading
    Isik, Gonca Ozdemir
    Ozer, A. Nevra
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (05) : 1102 - 1114